113 related articles for article (PubMed ID: 8057670)
21. Bcl-2 rearrangement in Hodgkin's disease and reactive lymph nodes.
Corbally N; Grogan L; Keane MM; Devaney DM; Dervan PA; Carney DN
Am J Clin Pathol; 1994 Jun; 101(6):756-60. PubMed ID: 8209865
[TBL] [Abstract][Full Text] [Related]
22. Expression of bcl-2 protein and Epstein-Barr virus latent membrane protein in Hodgkin's disease.
Kordek R; Biernat W; Kupnicka D; Woźniak L
Pol J Pathol; 1994; 45(4):279-81. PubMed ID: 7697330
[TBL] [Abstract][Full Text] [Related]
23. Incidence of Epstein-Barr virus bcl-2 expression and chromosomal translocation t(14;18) in large cell lymphoma associated with paragranuloma (lymphocyte-predominant Hodgkin's disease).
Hansmann ML; Shibata D; Lorenzen J; Hell K; Nathwani BN; Fischer R
Hum Pathol; 1994 Mar; 25(3):240-3. PubMed ID: 8150454
[TBL] [Abstract][Full Text] [Related]
24. 5'-->3' exonuclease-based real-time PCR assays for detecting the t(14;18)(q32;21): a survey of 162 malignant lymphomas and reactive specimens.
Estalilla OC; Medeiros LJ; Manning JT; Luthra R
Mod Pathol; 2000 Jun; 13(6):661-6. PubMed ID: 10874671
[TBL] [Abstract][Full Text] [Related]
25. Involvement of the bcl-2 gene in Hodgkin's disease.
Stetler-Stevenson M; Crush-Stanton S; Cossman J
J Natl Cancer Inst; 1990 May; 82(10):855-8. PubMed ID: 2185367
[TBL] [Abstract][Full Text] [Related]
26. Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma.
Dirks W; Nolte M; Werner M; Jäger K; Koch C; Drexler HG
Leukemia; 1996 Jan; 10(1):150-8. PubMed ID: 8558921
[TBL] [Abstract][Full Text] [Related]
27. [Bcl-2 in potentials precursors of nodular paragranuloma and its dedifferentiated variant (large cell B-lymphoma)].
Lorenzen J; Hansmann ML; Shibata D; Hell K; Klöckner A; Pezzella F; Fischer R
Verh Dtsch Ges Pathol; 1992; 76():169-72. PubMed ID: 1283252
[TBL] [Abstract][Full Text] [Related]
28. Single-cell analysis of the t(14;18)(q32;q21) chromosomal translocation in Hodgkin's disease demonstrates the absence of this translocation in neoplastic Hodgkin and Reed-Sternberg cells.
Gravel S; Delsol G; Al Saati T
Blood; 1998 Apr; 91(8):2866-74. PubMed ID: 9531597
[TBL] [Abstract][Full Text] [Related]
29. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.
Weiss LM; Warnke RA; Sklar J; Cleary ML
N Engl J Med; 1987 Nov; 317(19):1185-9. PubMed ID: 3657890
[TBL] [Abstract][Full Text] [Related]
30. Internal DNA deletion within the BCL-6 gene on untranslocated chromosome in non-Hodgkin's lymphoma with 3q27 abnormality.
Nakamura Y; Miki T; Miura I; Hashimoto K; Miura A; Akimoto K; Hirosawa S; Saito K; Enokihara H; Furusawa S; Shishido H
Leukemia; 1996 Apr; 10(4):658-61. PubMed ID: 8618443
[TBL] [Abstract][Full Text] [Related]
31. Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster.
Williams ME; Swerdlow SH; Meeker TC
Leukemia; 1993 Sep; 7(9):1437-40. PubMed ID: 8371593
[TBL] [Abstract][Full Text] [Related]
32. An immunocytochemical study of p53 and bcl-2 protein expression in Hodgkin's disease.
Doussis IA; Pezzella F; Lane DP; Gatter KC; Mason DY
Am J Clin Pathol; 1993 Jun; 99(6):663-7. PubMed ID: 8322700
[TBL] [Abstract][Full Text] [Related]
33. t(2;18) and t(18;22) variant chromosomal translocations and bcl-2 gene rearrangements in human malignant lymphomas.
Larsen CJ; Mecucci C; Leroux D
Nouv Rev Fr Hematol (1978); 1990; 32(6):401-3. PubMed ID: 2129304
[TBL] [Abstract][Full Text] [Related]
34. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?
Brink AA; Oudejans JJ; van den Brule AJ; Kluin PM; Horstman A; Ossenkoppele GJ; van Heerde P; Jiwa M; Meijer CJ
Mod Pathol; 1998 Apr; 11(4):376-83. PubMed ID: 9578089
[TBL] [Abstract][Full Text] [Related]
35. Frequent expression of the cell death-inducing gene Bax in Reed-Sternberg cells of Hodgkin's disease.
Brousset P; Benharroch D; Krajewski S; Laurent G; Meggetto F; Rigal-Huguet F; Gopas J; Prinsloo I; Pris J; Delsol G; Reed JC; Schlaifer D
Blood; 1996 Mar; 87(6):2470-5. PubMed ID: 8630413
[TBL] [Abstract][Full Text] [Related]
36. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma.
Bräuninger A; Hansmann ML; Strickler JG; Dummer R; Burg G; Rajewsky K; Küppers R
N Engl J Med; 1999 Apr; 340(16):1239-47. PubMed ID: 10210707
[TBL] [Abstract][Full Text] [Related]
37. [Localization of apoptosis-antagonizing bcl-2 translated product in Hodgkin's disease].
Chen XQ; Wang WL; Huang GS
Zhonghua Yi Xue Za Zhi; 1994 Oct; 74(10):618-20, 647. PubMed ID: 7842340
[TBL] [Abstract][Full Text] [Related]
38. Lymphocyte predominance Hodgkin's disease (nodular paragranuloma)--a bcl-2 negative germinal centre lymphoma.
Algara P; Martinez P; Sanchez L; Villuendas R; Orradre JL; Oliva H; Piris MA
Histopathology; 1991 Jul; 19(1):69-75. PubMed ID: 1916688
[TBL] [Abstract][Full Text] [Related]
39. Concurrent activation of c-myc and inactivation of bcl-2 by chromosomal translocation in a lymphoblastic lymphoma cell line.
Kiem HP; Nourse J; Saltman DL; Blume KG; Cleary ML
Oncogene; 1990 Dec; 5(12):1815-9. PubMed ID: 2284100
[TBL] [Abstract][Full Text] [Related]
40. Molecular biologic studies of Hodgkin's disease.
Weiss LM; Chang KL
Semin Diagn Pathol; 1992 Nov; 9(4):272-8. PubMed ID: 1336209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
